Clinicopathologic aspects of E rosette negative T cell acute lymphocytic leukemia: A Pediatric Oncology Group study

M. J. Borowitz, B. L. Dowell, J. M. Boyett, D. J. Pullen, W. M. Crist, F. M. Quddus, J. M. Falletta, R. S. Metzgar

Research output: Contribution to journalArticle

Abstract

The Pediatric Oncology Group has studied 1,367 patients with non-B cell acute lymphocytic leukemia (ALL) of whom 186 (14%) had blasts that reacted with previously well-characterized heteroantisera, recognizing a T-lymphocyte specific surface membrane antigen (PT+). In 87 of these T cell cases, the leukemic cells failed to form at least 20% of sheep erythrocytic rosettes at 4°C. Comparison of clinicopathologic features among PT-, E-PT+, and E+ groups of patients revealed significant differences among them. E-PT+ patients were older than PT- patients, had higher white blood cell counts (WBCs) and were more likely to have a mediastinal mass, and thus contained a higher proportion of poor-risk patients. However, the E-PT+ patients were also significantly different from the more traditionally-defined E+ patients in that they had lower WBCs and hemoglobin levels, and less frequent lymphadenopathy or mediastinal mass. In many respects, then, E-PT+ patients were intermediate in character between PT- and E+ patients. Our findings support the notion that further subclassification of ALL using antibodies recognizing lineage-specific surface determinants will permit recognition of groups of patients with distinct clinicopathologic features that may differ in prognosis or response to therapy. Such classification also focuses future biological studies on the pathogenesis of leukemias to immunologically well-defined subgroups of lymphoid neoplasms.

Original languageEnglish (US)
Pages (from-to)170-177
Number of pages8
JournalJournal of Clinical Oncology
Volume4
Issue number2
DOIs
StatePublished - Jan 1 1986
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Clinicopathologic aspects of E rosette negative T cell acute lymphocytic leukemia: A Pediatric Oncology Group study'. Together they form a unique fingerprint.

  • Cite this

    Borowitz, M. J., Dowell, B. L., Boyett, J. M., Pullen, D. J., Crist, W. M., Quddus, F. M., Falletta, J. M., & Metzgar, R. S. (1986). Clinicopathologic aspects of E rosette negative T cell acute lymphocytic leukemia: A Pediatric Oncology Group study. Journal of Clinical Oncology, 4(2), 170-177. https://doi.org/10.1200/JCO.1986.4.2.170